Cargando…
Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews
BACKGROUND: The European Academy of Allergy and Clinical Immunology (EAACI) is developing Guidelines on Allergen Immunotherapy (AIT) for Allergic Rhinoconjunctivitis (ARC). To inform the development of recommendations, we sought to critically assess the systematic review evidence on the effectivenes...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547534/ https://www.ncbi.nlm.nih.gov/pubmed/28794855 http://dx.doi.org/10.1186/s13601-017-0159-6 |
_version_ | 1783255712432914432 |
---|---|
author | Nurmatov, Ulugbek Dhami, Sangeeta Arasi, Stefania Roberts, Graham Pfaar, Oliver Muraro, Antonella Ansotegui, Ignacio J. Calderon, Moises Cingi, Cemal Durham, Stephen van Wijk, Roy Gerth Halken, Susanne Hamelmann, Eckard Hellings, Peter Jacobsen, Lars Knol, Edward Larenas-Linnemann, Desiree Lin, Sandra Y. Maggina, Vivian Oude-Elberink, Hanneke Pajno, Giovanni Panwankar, Ruby Pastorello, Elideanna Pitsios, Constantinos Rotiroti, Giuseppina Timmermans, Frans Tsilochristou, Olympia Varga, Eva-Maria Wilkinson, Jamie Williams, Andrew Worm, Margitta Zhang, Luo Sheikh, Aziz |
author_facet | Nurmatov, Ulugbek Dhami, Sangeeta Arasi, Stefania Roberts, Graham Pfaar, Oliver Muraro, Antonella Ansotegui, Ignacio J. Calderon, Moises Cingi, Cemal Durham, Stephen van Wijk, Roy Gerth Halken, Susanne Hamelmann, Eckard Hellings, Peter Jacobsen, Lars Knol, Edward Larenas-Linnemann, Desiree Lin, Sandra Y. Maggina, Vivian Oude-Elberink, Hanneke Pajno, Giovanni Panwankar, Ruby Pastorello, Elideanna Pitsios, Constantinos Rotiroti, Giuseppina Timmermans, Frans Tsilochristou, Olympia Varga, Eva-Maria Wilkinson, Jamie Williams, Andrew Worm, Margitta Zhang, Luo Sheikh, Aziz |
author_sort | Nurmatov, Ulugbek |
collection | PubMed |
description | BACKGROUND: The European Academy of Allergy and Clinical Immunology (EAACI) is developing Guidelines on Allergen Immunotherapy (AIT) for Allergic Rhinoconjunctivitis (ARC). To inform the development of recommendations, we sought to critically assess the systematic review evidence on the effectiveness, safety and cost-effectiveness of AIT for ARC. METHODS: We undertook a systematic overview, which involved searching nine international biomedical databases from inception to October 31, 2015. Studies were independently screened by two reviewers against pre-defined eligibility criteria and critically appraised using the Critical Appraisal Skills Programme (CASP) Systematic Review Checklist for systematic reviews. Data were descriptively synthesized. RESULTS: Our searches yielded a total of 5932 potentially eligible studies, from which 17 systematic reviews met our inclusion criteria. Eight of these were judged to be of high, five moderate and three low quality. These reviews suggested that, in carefully selected patients, subcutaneous (SCIT) and sublingual (SLIT) immunotherapy resulted in significant reductions in symptom scores and medication requirements. Serious adverse outcomes were rare for both SCIT and SLIT. Two systematic reviews reported some evidence of potential cost savings associated with use of SCIT and SLIT. CONCLUSIONS: We found moderate-to-strong evidence that SCIT and SLIT can, in appropriately selected patients, reduce symptoms and medication requirements in patients with ARC with reassuring safety data. This evidence does however need to be interpreted with caution, particularly given the heterogeneity in the populations, allergens and protocols studied. There is a lack of data on the relative effectiveness, cost-effectiveness and safety of SCIT and SLIT. We are now systematically reviewing all the primary studies, including recent evidence that has not been incorporated into the published systematic reviews. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13601-017-0159-6) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5547534 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-55475342017-08-09 Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews Nurmatov, Ulugbek Dhami, Sangeeta Arasi, Stefania Roberts, Graham Pfaar, Oliver Muraro, Antonella Ansotegui, Ignacio J. Calderon, Moises Cingi, Cemal Durham, Stephen van Wijk, Roy Gerth Halken, Susanne Hamelmann, Eckard Hellings, Peter Jacobsen, Lars Knol, Edward Larenas-Linnemann, Desiree Lin, Sandra Y. Maggina, Vivian Oude-Elberink, Hanneke Pajno, Giovanni Panwankar, Ruby Pastorello, Elideanna Pitsios, Constantinos Rotiroti, Giuseppina Timmermans, Frans Tsilochristou, Olympia Varga, Eva-Maria Wilkinson, Jamie Williams, Andrew Worm, Margitta Zhang, Luo Sheikh, Aziz Clin Transl Allergy Review BACKGROUND: The European Academy of Allergy and Clinical Immunology (EAACI) is developing Guidelines on Allergen Immunotherapy (AIT) for Allergic Rhinoconjunctivitis (ARC). To inform the development of recommendations, we sought to critically assess the systematic review evidence on the effectiveness, safety and cost-effectiveness of AIT for ARC. METHODS: We undertook a systematic overview, which involved searching nine international biomedical databases from inception to October 31, 2015. Studies were independently screened by two reviewers against pre-defined eligibility criteria and critically appraised using the Critical Appraisal Skills Programme (CASP) Systematic Review Checklist for systematic reviews. Data were descriptively synthesized. RESULTS: Our searches yielded a total of 5932 potentially eligible studies, from which 17 systematic reviews met our inclusion criteria. Eight of these were judged to be of high, five moderate and three low quality. These reviews suggested that, in carefully selected patients, subcutaneous (SCIT) and sublingual (SLIT) immunotherapy resulted in significant reductions in symptom scores and medication requirements. Serious adverse outcomes were rare for both SCIT and SLIT. Two systematic reviews reported some evidence of potential cost savings associated with use of SCIT and SLIT. CONCLUSIONS: We found moderate-to-strong evidence that SCIT and SLIT can, in appropriately selected patients, reduce symptoms and medication requirements in patients with ARC with reassuring safety data. This evidence does however need to be interpreted with caution, particularly given the heterogeneity in the populations, allergens and protocols studied. There is a lack of data on the relative effectiveness, cost-effectiveness and safety of SCIT and SLIT. We are now systematically reviewing all the primary studies, including recent evidence that has not been incorporated into the published systematic reviews. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13601-017-0159-6) contains supplementary material, which is available to authorized users. BioMed Central 2017-08-08 /pmc/articles/PMC5547534/ /pubmed/28794855 http://dx.doi.org/10.1186/s13601-017-0159-6 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Nurmatov, Ulugbek Dhami, Sangeeta Arasi, Stefania Roberts, Graham Pfaar, Oliver Muraro, Antonella Ansotegui, Ignacio J. Calderon, Moises Cingi, Cemal Durham, Stephen van Wijk, Roy Gerth Halken, Susanne Hamelmann, Eckard Hellings, Peter Jacobsen, Lars Knol, Edward Larenas-Linnemann, Desiree Lin, Sandra Y. Maggina, Vivian Oude-Elberink, Hanneke Pajno, Giovanni Panwankar, Ruby Pastorello, Elideanna Pitsios, Constantinos Rotiroti, Giuseppina Timmermans, Frans Tsilochristou, Olympia Varga, Eva-Maria Wilkinson, Jamie Williams, Andrew Worm, Margitta Zhang, Luo Sheikh, Aziz Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews |
title | Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews |
title_full | Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews |
title_fullStr | Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews |
title_full_unstemmed | Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews |
title_short | Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews |
title_sort | allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547534/ https://www.ncbi.nlm.nih.gov/pubmed/28794855 http://dx.doi.org/10.1186/s13601-017-0159-6 |
work_keys_str_mv | AT nurmatovulugbek allergenimmunotherapyforallergicrhinoconjunctivitisasystematicoverviewofsystematicreviews AT dhamisangeeta allergenimmunotherapyforallergicrhinoconjunctivitisasystematicoverviewofsystematicreviews AT arasistefania allergenimmunotherapyforallergicrhinoconjunctivitisasystematicoverviewofsystematicreviews AT robertsgraham allergenimmunotherapyforallergicrhinoconjunctivitisasystematicoverviewofsystematicreviews AT pfaaroliver allergenimmunotherapyforallergicrhinoconjunctivitisasystematicoverviewofsystematicreviews AT muraroantonella allergenimmunotherapyforallergicrhinoconjunctivitisasystematicoverviewofsystematicreviews AT ansoteguiignacioj allergenimmunotherapyforallergicrhinoconjunctivitisasystematicoverviewofsystematicreviews AT calderonmoises allergenimmunotherapyforallergicrhinoconjunctivitisasystematicoverviewofsystematicreviews AT cingicemal allergenimmunotherapyforallergicrhinoconjunctivitisasystematicoverviewofsystematicreviews AT durhamstephen allergenimmunotherapyforallergicrhinoconjunctivitisasystematicoverviewofsystematicreviews AT vanwijkroygerth allergenimmunotherapyforallergicrhinoconjunctivitisasystematicoverviewofsystematicreviews AT halkensusanne allergenimmunotherapyforallergicrhinoconjunctivitisasystematicoverviewofsystematicreviews AT hamelmanneckard allergenimmunotherapyforallergicrhinoconjunctivitisasystematicoverviewofsystematicreviews AT hellingspeter allergenimmunotherapyforallergicrhinoconjunctivitisasystematicoverviewofsystematicreviews AT jacobsenlars allergenimmunotherapyforallergicrhinoconjunctivitisasystematicoverviewofsystematicreviews AT knoledward allergenimmunotherapyforallergicrhinoconjunctivitisasystematicoverviewofsystematicreviews AT larenaslinnemanndesiree allergenimmunotherapyforallergicrhinoconjunctivitisasystematicoverviewofsystematicreviews AT linsandray allergenimmunotherapyforallergicrhinoconjunctivitisasystematicoverviewofsystematicreviews AT magginavivian allergenimmunotherapyforallergicrhinoconjunctivitisasystematicoverviewofsystematicreviews AT oudeelberinkhanneke allergenimmunotherapyforallergicrhinoconjunctivitisasystematicoverviewofsystematicreviews AT pajnogiovanni allergenimmunotherapyforallergicrhinoconjunctivitisasystematicoverviewofsystematicreviews AT panwankarruby allergenimmunotherapyforallergicrhinoconjunctivitisasystematicoverviewofsystematicreviews AT pastorelloelideanna allergenimmunotherapyforallergicrhinoconjunctivitisasystematicoverviewofsystematicreviews AT pitsiosconstantinos allergenimmunotherapyforallergicrhinoconjunctivitisasystematicoverviewofsystematicreviews AT rotirotigiuseppina allergenimmunotherapyforallergicrhinoconjunctivitisasystematicoverviewofsystematicreviews AT timmermansfrans allergenimmunotherapyforallergicrhinoconjunctivitisasystematicoverviewofsystematicreviews AT tsilochristouolympia allergenimmunotherapyforallergicrhinoconjunctivitisasystematicoverviewofsystematicreviews AT vargaevamaria allergenimmunotherapyforallergicrhinoconjunctivitisasystematicoverviewofsystematicreviews AT wilkinsonjamie allergenimmunotherapyforallergicrhinoconjunctivitisasystematicoverviewofsystematicreviews AT williamsandrew allergenimmunotherapyforallergicrhinoconjunctivitisasystematicoverviewofsystematicreviews AT wormmargitta allergenimmunotherapyforallergicrhinoconjunctivitisasystematicoverviewofsystematicreviews AT zhangluo allergenimmunotherapyforallergicrhinoconjunctivitisasystematicoverviewofsystematicreviews AT sheikhaziz allergenimmunotherapyforallergicrhinoconjunctivitisasystematicoverviewofsystematicreviews |